Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Retapamulin Microdialysis Feasibility Study
A Study to Evaluate the Feasibility of Microdialysis to Determine Skin Concentrations of Retapamulin in Healthy Volunteers
Status: Enrolling
Updated:  4/17/2014
GSK Investigational Site
mi
from
Gainesville, FL
Retapamulin Microdialysis Feasibility Study
A Study to Evaluate the Feasibility of Microdialysis to Determine Skin Concentrations of Retapamulin in Healthy Volunteers
Status: Enrolling
Updated: 4/17/2014
GSK Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Soft Tissue Ultrasound of Infections
Soft Tissue Ultrasound of Infections
Status: Enrolling
Updated:  4/24/2014
Rhode Island Hospital
mi
from
Providence, RI
Soft Tissue Ultrasound of Infections
Soft Tissue Ultrasound of Infections
Status: Enrolling
Updated: 4/24/2014
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes
Status: Enrolling
Updated:  4/28/2014
Alcon Call Center
mi
from
Fort Worth, TX
Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes
Status: Enrolling
Updated: 4/28/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Wick vs. No Wick: Does Method of Closure Affect Rate of Wound Infection?
Prospective, Randomized Controlled Trial of Wound Management After Ostomy Closure
Status: Enrolling
Updated:  5/1/2014
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Wick vs. No Wick: Does Method of Closure Affect Rate of Wound Infection?
Prospective, Randomized Controlled Trial of Wound Management After Ostomy Closure
Status: Enrolling
Updated: 5/1/2014
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Text Reminders to Immunize in a Managed Care Organization
Text Reminders to Immunize in a Managed Care Organization
Status: Enrolling
Updated:  6/2/2014
University of Rochester
mi
from
Rochester, NY
Text Reminders to Immunize in a Managed Care Organization
Text Reminders to Immunize in a Managed Care Organization
Status: Enrolling
Updated: 6/2/2014
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Arizona Medical Center
mi
from
Tucson, AZ
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Arizona Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Stanford Univ Med Ctr
mi
from
Stanford, CA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Yale University School of Medicine
mi
from
New Haven, CT
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Northwestern Memorial Hospital
mi
from
Chicago, IL
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Louisville Hospital
mi
from
Louisville, KY
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Louisville Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Maine Medical Center
mi
from
Scarborough, ME
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Maine Medical Center
mi
from
Scarborough, ME
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Maryland School of Medicine
mi
from
Baltimore, MD
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Massachusetts General Hospital
mi
from
Boston, MA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Umass Memorial Medical Center
mi
from
Worcester, MA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Umass Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Cleveland Clinic
mi
from
Cleveland, OH
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Oregon Health & Science University Hospital
mi
from
Portland, OR
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Oregon Health & Science University Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Abington Memorial Hospital
mi
from
Abington, PA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Medical University of South Carolina
mi
from
Charleston, SC
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Utah Healthcare
mi
from
Salt Lake City, UT
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Utah Healthcare
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated:  6/13/2014
Southeast Retina
mi
from
Augusta, GA
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated: 6/13/2014
Southeast Retina
mi
from
Augusta, GA
Click here to add this to my saved trials
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated:  6/13/2014
Retina Associates of Kentucky
mi
from
Lexington, KY
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated: 6/13/2014
Retina Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated:  6/13/2014
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Treatment for Presumed Ocular Histoplasmosis
Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)
Status: Enrolling
Updated: 6/13/2014
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
An Open-Label, Single Dose, Pharmacokinetic Study of AL-60371 Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery
Status: Enrolling
Updated:  7/6/2014
Alcon Call Center
mi
from
Fort Worth, TX
Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
An Open-Label, Single Dose, Pharmacokinetic Study of AL-60371 Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery
Status: Enrolling
Updated: 7/6/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Single Dose Study of Debio 1450 in Healthy Subjects
A Phase 1, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Escalating Oral Doses of Debio 1450 in Healthy Subjects
Status: Enrolling
Updated:  7/16/2014
Early Phase Clinical Unit
mi
from
Baltimore, MD
A Single Dose Study of Debio 1450 in Healthy Subjects
A Phase 1, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Escalating Oral Doses of Debio 1450 in Healthy Subjects
Status: Enrolling
Updated: 7/16/2014
Early Phase Clinical Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
Status: Enrolling
Updated:  7/22/2014
University of Miami Miller School of Medicine
mi
from
Miami, FL
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
Status: Enrolling
Updated: 7/22/2014
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Ledesma Foot and Ankle
mi
from
Phoenix, AZ
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Ledesma Foot and Ankle
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Foot and Ankle Clinic
mi
from
Los Angeles, CA
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Foot and Ankle Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Samuel Merritt University
mi
from
Oakland, CA
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Samuel Merritt University
mi
from
Oakland, CA
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
ASAP Urgent-Care
mi
from
Hamden, CT
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
ASAP Urgent-Care
mi
from
Hamden, CT
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Phoenix Medical Research
mi
from
Miami, FL
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Phoenix Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Med Research of Florida, LCC
mi
from
Miami, FL
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Med Research of Florida, LCC
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Miami Center for Clinical Research, LLC
mi
from
Miami, FL
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Miami Center for Clinical Research, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Unlimited Medical Research, LLC
mi
from
Miami, FL
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Unlimited Medical Research, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Advance Medical Research Center
mi
from
Miami, FL
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Advance Medical Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Sweet Hope Research Specialty, Inc.
mi
from
Miami Lakes, FL
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Sweet Hope Research Specialty, Inc.
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Research Integrity, Llc
mi
from
Owensboro, KY
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Research Integrity, Llc
mi
from
Owensboro, KY
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Paddington Testing Company
mi
from
Philadelphia, PA
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Paddington Testing Company
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
AllCare Foot & Ankle, PA
mi
from
Arlington, TX
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
AllCare Foot & Ankle, PA
mi
from
Arlington, TX
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated:  7/24/2014
Coastal Podiatry Group
mi
from
Virginia Beach, VA
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Coastal Podiatry Group
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Ledesma Foot and Ankle
mi
from
Phoenix, AZ
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Ledesma Foot and Ankle
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Foot and Ankle Clinic
mi
from
Los Angeles, CA
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Foot and Ankle Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Samuel Merritt University
mi
from
Oakland, CA
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Samuel Merritt University
mi
from
Oakland, CA
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
ASAP Urgent-Care
mi
from
Hamden, CT
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
ASAP Urgent-Care
mi
from
Hamden, CT
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Unlimited Medical Research, LLC
mi
from
Miami, FL
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Unlimited Medical Research, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Miami Center for Clinical Research, LLC
mi
from
Miami, FL
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Miami Center for Clinical Research, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Phoenix Medical Research
mi
from
Miami, FL
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Phoenix Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials